David R. Lynch

Neurology
3400 Civic Center Boulevard
South Pavilion, 2nd Floor
Philadelphia, PA 19104

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 192 publications

Impaired Glur2 palmitoylation in cerebellar Purkinje cells of a Friedreich ataxia mouse model.

Impaired Glur2 palmitoylation in cerebellar Purkinje cells of a Friedreich ataxia mouse model.

Journal: Experimental neurology
Published: May 11, 2026

FXN protomutations are the source of pathogenic expanded GAA alleles in Friedreich ataxia and explain its unequal population distribution.

FXN protomutations are the source of pathogenic expanded GAA alleles in Friedreich ataxia and explain its unequal population distribution.

Journal: Human molecular genetics
Published: May 04, 2026

Advances in Gene and Cellular Therapy in Friedreich Ataxia.

Advances in Gene and Cellular Therapy in Friedreich Ataxia.

Journal: Molecular diagnosis & therapy
Published: March 27, 2026

Generation of Friedreich's ataxia induced pluripotent stem cells carrying the FXN c.165 + 5G>C splicing mutation.

Generation of Friedreich's ataxia induced pluripotent stem cells carrying the FXN c.165 + 5G>C splicing mutation.

Journal: Stem cell research
Published: February 19, 2026

Stem Cell Transplantation in Friedreich Ataxia: Cure for Leukemia but No Effect on Neurological Progression.

Stem Cell Transplantation in Friedreich Ataxia: Cure for Leukemia but No Effect on Neurological Progression.

Journal: Annals of clinical and translational neurology
Published: February 04, 2026

Compound Heterozygote Friedreich Ataxia Patients With Covert Proximal FXN Gene Deletions.

Compound Heterozygote Friedreich Ataxia Patients With Covert Proximal FXN Gene Deletions.

Journal: Annals of clinical and translational neurology
Published: January 15, 2026

Peripheral frataxin levels govern long-term clinical progression in Friedreich ataxia.

Peripheral frataxin levels govern long-term clinical progression in Friedreich ataxia.

Journal: BMJ neurology open
Published: January 13, 2026

Safety and efficacy of individualised exercise and NAD+ precursor supplementation in patients with Friedreich's ataxia in the USA: a single-centre, 2 × 2 factorial, randomised controlled trial.

Safety and efficacy of individualised exercise and NAD+ precursor supplementation in patients with Friedreich's ataxia in the USA: a single-centre, 2 × 2 factorial, randomised controlled trial.

Journal: The Lancet. Neurology
Published: January 12, 2026

Listening in Spatialized Noise-Sentences (LiSN-S) as a Measure of Auditory Function in Friedreich Ataxia.

Listening in Spatialized Noise-Sentences (LiSN-S) as a Measure of Auditory Function in Friedreich Ataxia.

Journal: Cerebellum (London, England)
Published: December 30, 2025

Neuropathology of Friedreich ataxia and its links to metabolic pathways.

Neuropathology of Friedreich ataxia and its links to metabolic pathways.

Journal: Neurodegenerative disease management
Published: December 25, 2025

Myo-inositol elevation as an in vivo marker of reactive gliosis in pediatric Friedreich ataxia: evidence from HERMES-edited MR spectroscopy.

Myo-inositol elevation as an in vivo marker of reactive gliosis in pediatric Friedreich ataxia: evidence from HERMES-edited MR spectroscopy.

Journal: NeuroImage. Clinical
Published: October 08, 2025

Unrecognized high prevalence of expanded composite repeats in Friedreich ataxia.

Unrecognized high prevalence of expanded composite repeats in Friedreich ataxia.

Journal: Human molecular genetics
Published: October 02, 2025
Showing 1-12 of 192

Last Updated: 09/26/2026